<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1699-695X</journal-id>
<journal-title><![CDATA[Revista Clínica de Medicina de Familia]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Clin Med Fam]]></abbrev-journal-title>
<issn>1699-695X</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Española de Medicina de Familia y Comunitaria]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1699-695X2018000300154</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Abordaje del dolor crónico no oncológico]]></article-title>
<article-title xml:lang="en"><![CDATA[Management of chronic non-malignant pain]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Berrocoso Martínez]]></surname>
<given-names><![CDATA[Alberto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Arriba Muñoz]]></surname>
<given-names><![CDATA[Leonor de]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Arcega Baraza]]></surname>
<given-names><![CDATA[Adriana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Centro de Salud de Torrijos Consultorios Locales de Alcabón y Val de Santo Domingo ]]></institution>
<addr-line><![CDATA[Torrijos Toledo]]></addr-line>
<country>España</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital Tres Culturas  ]]></institution>
<addr-line><![CDATA[Toledo ]]></addr-line>
<country>España</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Unidad Docente Multiprofesional de Atención Familiar y Comunitaria de Toledo  ]]></institution>
<addr-line><![CDATA[Toledo ]]></addr-line>
<country>España</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2018</year>
</pub-date>
<volume>11</volume>
<numero>3</numero>
<fpage>154</fpage>
<lpage>159</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S1699-695X2018000300154&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S1699-695X2018000300154&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S1699-695X2018000300154&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN El dolor crónico no oncológico es una patología importante e incapacitante, con elevado coste sanitario. El abordaje debe estar centrado en el paciente, debiendo realizar un diagnóstico etiológico del dolor, identificación del tipo de dolor (nociceptivo, neuropático o mixto), utilización de escalas para valoración de la intensidad del dolor y de la calidad de vida, que nos ayudarán a ir viendo la evolución. Realizaremos un plan de tratamiento integral que incluya unos objetivos claros y realistas, junto a la toma optimizada de medicación y siempre teniendo en consideración la opinión y preferencias del paciente. No podemos olvidar la mejora de la capacidad funcional, la realización de actividad física adecuada y los cambios en el estilo de vida. Usaremos los fármacos a la menor dosis efectiva y durante el menor tiempo posible. Debemos reevaluar al paciente de forma programada, sobre todo en aquellos que tratamos con opioides potentes.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT Chronic non-malignant pain is an important and disabling pathology, with high healthcare costs. Its managementshould be focused on the patient, requiring an etiological diagnosis of pain, identification of the type of pain (nociceptive, neuropathic, or mixed), use of scales to assess pain intensity and quality of life, which will help us to see the evolution. We will carry out a comprehensive treatment plan that includes clear and realistic objectives, together with the optimized taking of medication, and always taking into consideration the opinion and preferences of the patient. We must not forget the improvement of functional capacity, adequate physical activity and changes in lifestyle. We will use drugs in the lowest effective doses and for the shortest periods of time possible. We must reevaluate the patient on a scheduled basis, especially those treated with potent opioids.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Dolor Crónico]]></kwd>
<kwd lng="es"><![CDATA[Analgesia]]></kwd>
<kwd lng="es"><![CDATA[Analgésicos]]></kwd>
<kwd lng="es"><![CDATA[Opioides]]></kwd>
<kwd lng="en"><![CDATA[Chronic Pain]]></kwd>
<kwd lng="en"><![CDATA[Analgesia]]></kwd>
<kwd lng="en"><![CDATA[Analgesics]]></kwd>
<kwd lng="en"><![CDATA[Opioids]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[López]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Penide]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Portalo]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Arroyo]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dolor crónico no oncológico]]></article-title>
<source><![CDATA[BolFarmacoterCastilla-La Mancha]]></source>
<year>2014</year>
<volume>XV</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-8</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guerra de Hoyos]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<source><![CDATA[Dolor crónico no oncológico. Proceso asistencial integrado]]></source>
<year>2014</year>
<edition>2</edition>
<publisher-loc><![CDATA[Sevilla ]]></publisher-loc>
<publisher-name><![CDATA[Consejería de Igualdad, Salud y Políticas Sociales]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Turk]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
<name>
<surname><![CDATA[Wilson]]></surname>
<given-names><![CDATA[HD]]></given-names>
</name>
<name>
<surname><![CDATA[Cahana]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Treatment of chronic non-cancer pain]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2011</year>
<volume>377</volume>
<numero>9784</numero>
<issue>9784</issue>
<page-range>2226-35</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Torralba]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Miguel]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Darba]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Situación actual del dolor crónico en España: iniciativa &#8220;PainProposal&#8221;]]></article-title>
<source><![CDATA[RevSocEsp Dolor]]></source>
<year>2014</year>
<volume>21</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>16-22</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Breivik]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Collett]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Ventafridda]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Cohen]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Gallacher]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment]]></article-title>
<source><![CDATA[Eur J Pain]]></source>
<year>2006</year>
<volume>10</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>287-333</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Henche]]></surname>
<given-names><![CDATA[AI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[El auge de la analgesia opioide. Problemas relacionados con el uso a largo plazo]]></article-title>
<source><![CDATA[Bol Farmacoter Castilla-La Mancha]]></source>
<year>2016</year>
<volume>XVII</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>1-18</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sánchez Jimenez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Tejedor Varillas]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Carrascal Garrido]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[La atención al paciente con dolor crónico no oncológico en Atención Primaria. Documento de Consenso]]></source>
<year></year>
<publisher-loc><![CDATA[España ]]></publisher-loc>
<publisher-name><![CDATA[Sociedad Española de Médicos Generales y de Familia, Sociedad Española de Medicina Familiar y Comunitaria, Sociedad Española de Médicos de Atención Primaria]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rojas Corrales]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Cuéllar Obispo]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Domínguez Camacho]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dolor crónico no oncológico: tratamiento farmacológico]]></article-title>
<source><![CDATA[Bol Ter Andal]]></source>
<year>2015</year>
<volume>30</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>21-8</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Miró]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Dolor crónico. Procedimientos de evaluación e intervención psicológica]]></source>
<year>2003</year>
<edition>1</edition>
<publisher-loc><![CDATA[Bilbao ]]></publisher-loc>
<publisher-name><![CDATA[Desclee de Brouwer]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Muñoz-Bellerín]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Plan para la promoción de la actividad física y la alimentación equilibrada 2004-2008]]></source>
<year></year>
<publisher-loc><![CDATA[Sevilla ]]></publisher-loc>
<publisher-name><![CDATA[Junta de Andalucía, Consejería de Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McAlindon]]></surname>
<given-names><![CDATA[TE]]></given-names>
</name>
<name>
<surname><![CDATA[Bannuru]]></surname>
<given-names><![CDATA[RE]]></given-names>
</name>
<name>
<surname><![CDATA[Sullivan]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Arden]]></surname>
<given-names><![CDATA[NK]]></given-names>
</name>
<name>
<surname><![CDATA[Berenbaum]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Bierma-Zeinstra]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[OARSI guidelines for the non-surgical management of knee osteoarthritis]]></article-title>
<source><![CDATA[Osteoarthritis Cartilage]]></source>
<year>2014</year>
<volume>22</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>363-88</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hochberg]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Altman]]></surname>
<given-names><![CDATA[RD]]></given-names>
</name>
<name>
<surname><![CDATA[April]]></surname>
<given-names><![CDATA[KT]]></given-names>
</name>
<name>
<surname><![CDATA[Benkhalti]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Guyatt]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[McGowan]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[American College of Rheumatology 2012 Recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee]]></article-title>
<source><![CDATA[ArthritisCare Res (Hoboken)]]></source>
<year>2012</year>
<volume>64</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>465-74</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="book">
<collab>Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)</collab>
<source><![CDATA[Diclofenaco y riesgo cardiovascular. Restricciones de uso]]></source>
<year>2013</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Ministerio de Sanidad, Servicios Sociales e Igualdad]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="book">
<collab>Scottish Intercollegiate Guidelines Network (SIGN)</collab>
<source><![CDATA[Management of chronic pain]]></source>
<year>2013</year>
<numero>136</numero>
<issue>136</issue>
<publisher-loc><![CDATA[Edimburgo ]]></publisher-loc>
<publisher-name><![CDATA[SIGN]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McGettigan]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Henry]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies]]></article-title>
<source><![CDATA[PLoS Med]]></source>
<year>2011</year>
<volume>8</volume>
<numero>9</numero>
<issue>9</issue>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Els]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Jackson]]></surname>
<given-names><![CDATA[TD]]></given-names>
</name>
<name>
<surname><![CDATA[Kunyk]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Lappi]]></surname>
<given-names><![CDATA[VG]]></given-names>
</name>
<name>
<surname><![CDATA[Sonnenberg]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Hagtvedt]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews]]></article-title>
<source><![CDATA[Cochrane Database Syst Rev]]></source>
<year>2017</year>
<numero>10</numero>
<issue>10</issue>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Palanca Sánchez]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Puig Riera de Conías]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Elola Somoza]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Bernal Sobrino]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Paniagua Caparrós]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
</person-group>
<collab>Grupo de Expertos</collab>
<source><![CDATA[Unidad de tratamiento de dolor: estándares y recomendaciones]]></source>
<year>2011</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Ministerio de Sanidad, Política Social e Igualdad]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saarto]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Wiffen]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Antidepressants for neuropathic pain: a Cochrane review]]></article-title>
<source><![CDATA[J NeurolNeurosurgPsychiatry]]></source>
<year>2010</year>
<volume>81</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1372-3</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[González-Escalada]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Camba]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Portolés]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[López]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Recomendaciones para el tratamiento del dolor neuropático]]></article-title>
<source><![CDATA[RevSocEsp Dolor]]></source>
<year>2009</year>
<volume>16</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>445-67</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="book">
<collab>Dirección General de Coordinación de la Atención al Ciudadano y Humanización de la Asistencia Sanitaria. Consejería de Sanidad</collab>
<source><![CDATA[Estrategia de dolor 2017-2020]]></source>
<year>2017</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Consejería de Sanidad. Comunidad de Madrid]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
